000 01471 a2200385 4500
005 20250511181753.0
264 0 _c19920224
008 199202s 0 0 eng d
022 _a0002-9378
024 7 _a10.1016/0002-9378(92)91865-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSu, H C
245 0 0 _aCatecholamines modulate epidermal growth factor-induced prostaglandin E2 production in amnion-like (WISH) cells by means of a cyclic adenosine monophosphate-dependent pathway.
_h[electronic resource]
260 _bAmerican journal of obstetrics and gynecology
_cJan 1992
300 _a236-41 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a1-Methyl-3-isobutylxanthine
_xpharmacology
650 0 4 _aAmnion
_xdrug effects
650 0 4 _aCatecholamines
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aColforsin
_xpharmacology
650 0 4 _aCyclic AMP
_xphysiology
650 0 4 _aDinoprostone
_xbiosynthesis
650 0 4 _aDopamine
_xpharmacology
650 0 4 _aEpidermal Growth Factor
_xpharmacology
650 0 4 _aEpinephrine
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNorepinephrine
_xpharmacology
650 0 4 _aPropranolol
_xpharmacology
700 1 _aFertel, R H
700 1 _aKniss, D A
773 0 _tAmerican journal of obstetrics and gynecology
_gvol. 166
_gno. 1 Pt 1
_gp. 236-41
856 4 0 _uhttps://doi.org/10.1016/0002-9378(92)91865-8
_zAvailable from publisher's website
999 _c1377236
_d1377236